With the results, it became evident that up to a 93% of patients with genotype 2 and viral loads below 400,000 UI/ml were reaching SVR with only 12-16 weeks of treatment if they were negative at week 4 indicating a rapid viral response Table 3 17-24.
En los resultados se hizo evidente que los pacientes con genotipo 2 y carga viral baja menor de 400.000 UI/ml, alcanzaban una RVS hasta en 93% con solo 12-16 semanas de tratamiento si eran negativos a la semana 4 lo que indica una respuesta viral rápida 17-24 tabla 3.